ITF Therapeutics-Givinostat Registry - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults, Children
Study Details
Full Title
A Prospective, Observational Study Evaluating the Real-World Experience of Givinostat in Patients with Duchenne Muscular Dystrophy
Principal Investigator
Natalie Katz, MD, PhD
Pediatric Neurologist
Protocol Number
IRB:
PRO00119323
NCT:
NCT07127978
Phase
Phase N/A
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment